Luc Tanguay
Keine laufenden Positionen mehr
Karriereverlauf von Luc Tanguay
Ehemalige bekannte Positionen von Luc Tanguay
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
THERATECHNOLOGIES INC. | Direktor/Vorstandsmitglied | 06.12.1993 | 06.04.2020 |
Vorstandsvorsitzender | 11.10.2012 | 06.04.2020 | |
Präsident | 11.10.2012 | 06.04.2020 | |
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Direktor/Vorstandsmitglied | 22.08.2006 | 31.03.2010 |
Valeo Management LP
Valeo Management LP Miscellaneous Commercial ServicesCommercial Services Valeo Management LP offers research commercialization services. The firm provides Life sciences and biotechnologies, engineering, information and communications technologies services. The company was founded in 2000 and is headquartered in Montreal, Canada. | Vorsitzender | - | - |
Ausbildung von Luc Tanguay
University of Sherbrooke | Graduate Degree |
Statistik
International
Kanada | 5 |
Operativ
Director/Board Member | 2 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
THERATECHNOLOGIES INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Health Technology |
Valeo Management LP
Valeo Management LP Miscellaneous Commercial ServicesCommercial Services Valeo Management LP offers research commercialization services. The firm provides Life sciences and biotechnologies, engineering, information and communications technologies services. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |
- Börse
- Insiders
- Luc Tanguay
- Erfahrung